Skip to main content


Findings from a recent pharmacovigilance study suggest men less than 45 years of age and with alopecia may have an increased risk of suicidality, depression, and anxiety with finasteride use.
Findings from a recent study highlight the prevalence of hidradenitis suppurativa among various populations.
FDA Approves Nonprescription Lotion for Treatment of Head Lice; Contact Dermatitis Caused by Personal Care Products Increasing; Biologics Associated With Lower Risk of COVID-19 Hospitalization; Long-Hauler Patients Show Prolonged Cutaneous Symptoms of COVID-19; Patients Report Immediate and Sustained Improvements in Severity, HRQL, and Mental Health in Two Phase 3 Clinical Trials
Vitamin D supplementation may be an effective add-on to topical atopic dermatitis therapy, according to the findings of a recent study.
Analysis from the COVID-19 Dermatology Registry revealed that some patients who develop cutaneous symptoms of the disease become “long haulers” with persistent skin symptoms lasting as long as 150 days. Data were presented in a late-breaking abstract by principal investigator Esther Freeman, MD, PhD, at EADV Virtual on October 29, 2020.
Data from an international registry showed that patients with psoriasis who received a biologic were less likely to be hospitalized vs patients who received a non-biologic systemic therapy. This data from the PsoProtect registry were published in the Journal of Allergy and Clinical Immunology.
In a recent study, researchers investigated whether clinical area could predict invasion of lentigo maligna.
A recent study found high heritability among patients with hidradenitis suppurativa (HS), suggesting a stronger than previously assumed genetic basis for this disease.
Findings from a recent study found risankizumab improved both moderate to severe psoriasis symptoms and patients’ quality of life.
Findings from a recent study showed patients with moderate to severe atopic dermatitis had a high burden of ocular surface disorders and related symptoms.
Back to Top